Market revenue in 2023 | USD 6.3 million |
Market revenue in 2030 | USD 30.9 million |
Growth rate | 25.4% (CAGR from 2023 to 2030) |
Largest segment | Drug optimization & repurposing |
Fastest growing segment | Drug Optimization & Repurposing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Optimization & Repurposing, Preclinical Testing |
Key market players worldwide | International Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Drug optimization & repurposing was the largest segment with a revenue share of 53.97% in 2023. Horizon Databook has segmented the Italy artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing implementation of AI for accelerating the expensive and cumbersome process of drug discovery is contributing to market growth in the country. In addition, implementation of AI supports pharmaceutical companies in identifying patterns and processes for drug discovery, including target identification.
In silico drug design, drug development, big data analytics, prediction of study risks, and patient matching. For these reasons, it is being trialed and/or deployed by pharmaceutical companies for developing their own advanced data analytics platforms that utilize AI.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy artificial intelligence in drug discovery market , including forecasts for subscribers. This country databook contains high-level insights into Italy artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account